[Chronic bronchitis and pulmonary emphysema. Pathology, physiopathology, clinical picture and therapy. 3. Therapy].
D000138:Acidosis / Q000188:drug therapy; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000485:Allergens / Q000009:adverse effects; D045930:Anabolic Agents / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000996:Antitussive Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002908:Chronic Disease; D006294:Health Resorts; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006935:Hypercapnia / Q000188:drug therapy; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008134:Long-Term Care; D010102:Oxygen Inhalation Therapy; D026741:Physical Therapy Modalities; D011656:Pulmonary Emphysema / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000628:therapy; D013449:Sulfonamides / Q000627:therapeutic use; D014611:Vaccination
D000305:Adrenal Cortex Hormones; D000485:Allergens; D045930:Anabolic Agents; D000900:Anti-Bacterial Agents; D000996:Antitussive Agents; D001993:Bronchodilator Agents; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D013449:Sulfonamides
Chronische Bronchitis und Lungenemphysem. Pathologie, Pathophysiologie, Klinik und Therapie. 3. Therapie.